The U.S. Food and Drug Administration issued a warning to generic drug maker, Impax Laboratories, Inc., regarding manufacturing practices in its Hayward, California pant. During a review conducted between Dec 13 and Jan 21, FDA inspectors identified problems with Impax’s sampling and testing procedures, as well as the process by which the company determines which [...]
